Suppr超能文献

[结直肠癌同时性肝转移同期肝切除的疗效分析]

[Outcome analysis of simultaneous liver resection for synchronous liver metastases from colorectal cancer].

作者信息

Hu Jun-jie, Zhou Zhi-xiang, Liang Jian-wei, Wang Zheng, Zhou Hai-tao, Zhong Yu-xin

机构信息

Department of Abdominal Surgery, Chinese Academy of Medical Sciences, Beijing, China.

出版信息

Zhonghua Zhong Liu Za Zhi. 2013 Jan;35(1):63-6. doi: 10.3760/cma.j.issn.0253-3766.2013.01.014.

Abstract

OBJECTIVE

To analyze the outcomes of simultaneous liver resection for patients who have primary colorectal cancer with synchronous hepatic metastases to see if there is any advantage for doing so.

METHODS

We retrospectively analyzed the medical records (1999 - 2009) of 53 consecutive patients with synchronously recognized primary colorectal carcinoma and hepatic metastases who underwent simultaneous (40 patients) or two-stage (13 patients) colonic and hepatic resections performed at our hospital.

RESULTS

There was no thirty-day mortality in both groups. The two groups had significant differences in mean operation duration [(212.9 ± 72.3) min vs. (326.5 ± 140.2) min, P = 0.014], mean blood loss [(337.5 ± 298.0) ml vs. (594.6 ± 430.5) ml, P = 0.020], post-operative hospital stay [(16.2 ± 8.1) day vs. (25.8 ± 8.5) day, P = 0.001]. The incidence rates of post-operative complications were 25.0% (10/40) and 53.8% (7/13), respectively, in the two groups (P = 0.053). The 1-, 3-, 5-year survival rates in the simultaneous resection group were 95.0%, 57.0% and 37.4%, respectively, with a median overall survival of 40.0 months and median disease-free survival of 14.0 months. The 1-, 3-, 5-year survival rates in the two-stage resection group were 92.3%, 58.7% and 36.7%, respectively, with a median overall survival of 38.0 months and median disease-free survival of 13.0 months. There were no significant differences between the two groups in respect of their survivals (P > 0.05).

CONCLUSIONS

Simultaneous colectomy and hepatectomy are safe and efficient for colorectal cancer patients who have synchronous colorectal liver metastases, with less complications and blood loss, and shorter hospital stay compared with the two-stage resection.

摘要

目的

分析同时行肝切除治疗原发性结直肠癌合并同步肝转移患者的疗效,以确定这样做是否有优势。

方法

我们回顾性分析了我院1999年至2009年期间连续53例同时确诊为原发性结直肠癌和肝转移的患者的病历,这些患者接受了同期(40例)或分期(13例)结肠和肝切除术。

结果

两组均无30天死亡率。两组在平均手术时间[(212.9±72.3)分钟对(326.5±140.2)分钟,P = 0.014]、平均失血量[(337.5±298.0)毫升对(594.6±430.5)毫升,P = 0.020]、术后住院时间[(16.2±8.1)天对(25.8±8.5)天,P = 0.001]方面存在显著差异。两组术后并发症发生率分别为25.0%(10/40)和53.8%(7/13)(P = 0.053)。同期切除组的1年、3年、5年生存率分别为95.0%、57.0%和37.4%,总生存中位数为40.0个月,无病生存中位数为14.0个月。分期切除组的1年、3年、5年生存率分别为92.3%、58.7%和36.7%,总生存中位数为38.0个月,无病生存中位数为13.0个月。两组在生存率方面无显著差异(P>0.05)。

结论

对于原发性结直肠癌合并同步肝转移的患者,同期结肠切除术和肝切除术是安全有效的,与分期切除相比,并发症更少、失血量更少且住院时间更短。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验